indirubin has been researched along with Glial Cell Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Rasoul, M; Chiocca, EA; Fernandez, SA; Godlewski, J; Kaur, B; Lawler, SE; Liu, F; Nowicki, MO; Press, R; Williams, SP | 1 |
1 other study(ies) available for indirubin and Glial Cell Tumors
| Article | Year |
|---|---|
Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glioma; Glycogen Synthase Kinase 3; Humans; Indoles; Mice; Neoplasm Invasiveness | 2011 |